De-Risking the drug discovery process of Oncology and Metabolic diseases
Excellence: Vitala Technologies brings together Organ-on-Chip (OoC), hyperpolarized magnetic resonance spectroscopic imaging (HP MRSI), and advanced data analysis tools to provide a patented and revolutionary test for the monitori...
Excellence: Vitala Technologies brings together Organ-on-Chip (OoC), hyperpolarized magnetic resonance spectroscopic imaging (HP MRSI), and advanced data analysis tools to provide a patented and revolutionary test for the monitoring of the efficacy in treatment of a new drug moving through the metabolic pathways of a cell. This new methodology provides the opportunity to set preclinical drug testing strategies that are more effective, faster, cheaper, and reduce animal use. The information obtained by this novel methodology will improve the future steps for drug candidates in advanced pre-clinical and clinical stages. Vitala’s analysis allows defining and executing on pre-clinical testing strategies, increasing the speed of the drug discovery process, and reducing its costs.
Impact: An increased accuracy in the early stages of the drug screening process will allow discarding inadequate pharmaceutical candidates before those reach the animal testing stage, reducing the number of animals used in the whole pre-clinical process. Moreover, our objective is to de-risk and revolutionise the entire drug discovery process, decreasing the direct and indirect costs associated with the pre-clinical drug discovery pipeline with our real-time, non-destructive, highly sensitive technology. Vitala’s impact will expand to later phases of drug discovery by preventing in-vitro and in vivo as well as human testing of drugs that in the absence of translatable models could have been deemed appropriate to proceed to later clinical trial stages.
Implementation and team: Vitala is formed by a management team of professionals with complementary backgrounds in the fields of microfluidics, imaging technologies and business administration. Vitala has already filled a PCT patent application and successfully completed an FTO, which gives our technology a green light to be exploited both in the EU and the USA with short and long term strategies in place.ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.